VPS26B, or Vacuolar Protein Sorting 26 Homolog B, is an integral component of the retromer complex, which is crucial for endosomal protein sorting and recycling. The retromer complex functions to transport proteins from the endosome back to the Golgi apparatus or to the plasma membrane, thus preventing their degradation in lysosomes. VPS26B specifically is thought to play a key role in recognizing and binding to cargo proteins that need to be recycled, thereby determining the specificity and efficiency of the retromer-mediated transport process. The proper functioning of this pathway is essential for maintaining cellular homeostasis, as it impacts a variety of cellular processes including signaling receptor recycling, cell surface protein composition, and intracellular communication.
The inhibition of VPS26B can lead to significant disruptions in the protein sorting and recycling processes within cells, potentially resulting in pathological conditions associated with defective protein trafficking such as neurodegenerative diseases or disorders of cellular metabolism. Inhibition can occur through various mechanisms. One potential method is the direct interference with the protein-protein interactions necessary for the assembly and function of the retromer complex. For example, competitive inhibitors or mutations within the VPS26B structure could prevent its binding to other components of the retromer or to the cargo proteins, disrupting the complex's functionality. Another mechanism could involve the misregulation of VPS26B expression, whether through transcriptional repression, RNA interference mechanisms that degrade VPS26B mRNA, or improper translation processes that lead to dysfunctional protein forms. Furthermore, post-translational modifications such as phosphorylation or ubiquitination might alter the stability or the localization of VPS26B within the cell, affecting its ability to participate effectively in the retromer complex. Understanding these inhibitory processes is critical for elucidating the role of VPS26B in cellular functioning and for identifying potential therapeutic targets for diseases caused by dysfunctional protein trafficking.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi apparatus, which can modulate trafficking processes involving VPS26B. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits tyrosine kinases, which play roles in endocytosis, possibly influencing VPS26B-associated pathways. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
This compound depletes cholesterol, disrupting lipid rafts and influencing endocytosis processes related to VPS26B. | ||||||
Tyrphostin A23 | 118409-57-7 | sc-3554 | 10 mg | $112.00 | 13 | |
Tyrphostin A23 inhibits endocytosis by blocking the function of tyrosine kinases, which can influence pathways associated with VPS26B. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
Filipin III is a disruptor of lipid rafts, which can affect endocytosis and processes linked to VPS26B. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A disrupts actin polymerization, which plays a key role in vesicle formation and can influence VPS26B functions. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole interferes with microtubule dynamics, essential for vesicle transport, which can affect VPS26B-associated pathways. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin inhibits the N-WASP-Arp2/3 complex, disrupting actin polymerization and potentially influencing VPS26B functions. | ||||||